MiR-3613-3p impairs IFN-induced immune response by targeting CMPK1 in chronic hepatitis B.
CONCLUSION: MiR-3613-3p impaired IFN-induced immune response by targeting CMPK1 in chronic hepatitis B.
PMID: 31201869 [PubMed - as supplied by publisher]
Source: Infection, Genetics and Evolution - Category: Genetics & Stem Cells Authors: Zhao Y, Yu Y, Ye L Tags: Infect Genet Evol Source Type: research
More News: Genetics | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver Cancer | Study | Vitamin B7